(Q46636533)

English

Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

scientific article published on 5 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

left ventricular hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

G Boner

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

M E Cooper

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

K McCarroll

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

B M Brenner

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

D de Zeeuw

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

P R Kowey

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

S Shahinfar

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

T Dickson

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

R S Crow

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

H-H Parving

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

RENAAL Investigators

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

publication date

5 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

48

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

1980-1987

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

https://scigraph.springernature.com/pub.10.1007/s00125-005-1893-1

0 references

Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-1893-1

21 January 2018

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-1893-1

21 January 2018

Epidemiology of cardiovascular disease in chronic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors. The example of albuminuria and the risk of cardiovascular disease in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical implications of diabetic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac disease in chronic uremia: pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin receptor blockers and myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of serial changes in left ventricular mass in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of left ventricular hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-005-1893-1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082528

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46636533&oldid=2123578175"